OXFORD, UK / ACCESS Newswire / June 15, 2026 /Fine Treatment has highlighted increasing interest in non-invasive therapeutic ...
U.S. Market Projected to Hit USD 7.06 Billion by 2035 While Europe Market Expected to Reach USD 6.42 Billion as Aging Male Population Fuels Demand for Advanced BPH Therapies.Austin, United States, May ...
(NASDAQ: ANGO), a medical technology company focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving patient quality of life, today ...
AngioDynamics has received approval from the US Food and Drug Administration (FDA) for an investigational device exemption ...
Frequent urination, urgency and waking up at night to urinate are often blamed on an enlarged prostate. However, doctors say ...
The prevalence of benign prostatic hyperplasia is increasing globally, according to a study published online Oct. 20 in The Lancet Healthy Longevity. Atalel Fentahun Awedew, M.D., from Addis Ababa ...
JW Pharmaceutical and JW Shinyak announced on the 10th that they held the "J STAR Symposium" at the Grand Walkerhill Seoul ...
Patients with gout, especially those younger than 60 years, have an increased risk for benign prostatic hyperplasia (BPH), according to a study published online Dec. 26 in Diagnostics. Woo Jin Bang, ...